“Focus on building quality into the clinical trial process through proactive compliance rather than ‘inspecting’ quality in,” David Burrow, director of the Office of Scientific Investigations within the Office of […]
Nearly half of attendees polled at the ACRP 2021 virtual conference yesterday (September 16) were either only “somewhat” (36%) or “not at all” (9%) prepared when the U.S. Food and […]
Rutgers University has pioneered a decentralized approach to clinical trials that is allowing researchers to achieve better scientific outcomes as they accelerate the pace of finding cures, recruit lower-income and […]
A growing number of drugs are being approved on the basis of indirect (surrogate) measures that do not always reliably predict outcomes that matter most to patients, such as living […]
Australian researchers have been awarded nearly $2.2 million by the U.S. National Cancer Institute (NCI) to test new treatment drugs for children with cancer over the next five years, so […]